Showing results (351-360 of 941) with videos related to

Sort By:
Pageof 95
Neurology and Therapy|October 26, 2016
Evaluation of Quality of Life in Patients With Narcolepsy Treated With Sodium Oxybate: Use of the 36-Item Short-Form Health Survey in a Clinical TrialRichard Bogan, Todd Swick, Mortimer Mamelak, et al.
Neurology and Therapy|November 24, 2016
Informal Care Time and Cost in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer's Disease: Determinants and Level of Change ObservedLoretto Lacey, Joel Bobula, Timothy Niecko, et al.
Neurology and Therapy|August 22, 2019
Effect of Anodal tDCS on Articulatory Accuracy, Word Production, and Syllable Repetition in Subjects with Aphasia: A Crossover, Double-Blinded, Sham-Controlled TrialCamila Vila-Nova, Pedro H Lucena, Rita Lucena, et al.
Neurology and Therapy|August 14, 2019
Can Generic Intravenous Levetiracetam Be Used for Acute Repetitive Convulsive Seizure or Status Epilepticus? A Randomized Controlled TrialRachot Wongjirattikarn, Kittisak Sawanyawisuth, Sineenard Pranboon, et al.
Neurology and Therapy|August 3, 2019
Bioavailability and Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets in Healthy Volunteers: Results from Three Randomized, Crossover, Open-Label, Phase 1 StudiesTina deVries, Angela Dentiste, Lata Handiwala, et al.
Neurology and Therapy|November 11, 2018
Patient Power Revolution in Multiple Sclerosis: Navigating the New FrontierDavid Yeandle, Peter Rieckmann, Gavin Giovannoni, et al.
Neurology and Therapy|March 16, 2019
An Overview of High-Efficacy Drugs for Multiple Sclerosis: Gulf Region Expert OpinionRaed Alroughani, Jihad Said Inshasi, Dirk Deleu, et al.
Neurology and Therapy|July 21, 2019
Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing-Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMS II TrialsAngelo Ghezzi, Tanuja Chitnis, Annik K-Laflamme, et al.
Neurology and Therapy|January 13, 2017
Natalizumab for Achieving Relapse-Free, T1 Gadolinium-Enhancing-Lesion-Free, and T2 Lesion-Free Status in Japanese Multiple Sclerosis Patients: A Phase 2 Trial SubanalysisTakahiko Saida, Jun-Ichi Kira, Shuji Kishida, et al.
Neurology and Therapy|February 7, 2022
Bioavailability and Safety of a New Highly Concentrated Midazolam Nasal Spray Compared to Buccal and Intravenous Midazolam Treatment in Chinese Healthy VolunteersHui Wang, Jie Huang, Shuang Yang, et al.
Pageof 95